Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

An overview of take-home naloxone programs in Australia.

Dwyer R, Olsen A, Fowlie C, Gough C, van Beek I, Jauncey M, Lintzeris N, Oh G, Dicka J, Fry CL, Hayllar J, Lenton S.

Drug Alcohol Rev. 2018 May;37(4):440-449. doi: 10.1111/dar.12812.

PMID:
29744980
2.

Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay.

Lamoury FMJ, Bajis S, Hajarizadeh B, Marshall AD, Martinello M, Ivanova E, Catlett B, Mowat Y, Marks P, Amin J, Smith J, Ezard N, Cock V, Hayllar J, Persing DH, Kleman M, Cunningham P, Dore GJ, Applegate TL, Grebely J; LiveRLife Study Group.

J Infect Dis. 2018 May 25;217(12):1889-1896. doi: 10.1093/infdis/jiy114.

PMID:
29534185
4.

Intestinal permeability and inflammation in patients on NSAIDs.

Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, Scott D, Gumpel MJ, Bjarnason I.

Gut. 1998 Oct;43(4):506-11.

5.

Aboriginal health.

Blackwell N, Hayllar J.

Lancet. 1998 May 2;351(9112):1363. No abstract available.

PMID:
9643831
6.

Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.

Somasundaram S, Rafi S, Hayllar J, Sigthorsson G, Jacob M, Price AB, Macpherson A, Mahmod T, Scott D, Wrigglesworth JM, Bjarnason I.

Gut. 1997 Sep;41(3):344-53.

7.
8.
9.

Gastroduodenal tolerability of highly specific cyclo-oxygenase-2 inhibitor.

Hayllar J, Bjarnason I.

Ital J Gastroenterol. 1996 Dec;28 Suppl 4:30-2.

PMID:
9032580
10.

Early pathogenic events in NSAID-induced gastrointestinal damage.

Bjarnason I, Hayllar J.

Ital J Gastroenterol. 1996 Dec;28 Suppl 4:19-22.

PMID:
9032577
11.

NSAIDs, Cox-2 inhibitors, and the gut.

Hayllar J, Bjarnason I.

Lancet. 1995 Dec 16;346(8990):1629. No abstract available.

PMID:
7500770
12.

NSAIDs, Cox-2 inhibitors, and the gut.

Hayllar J, Bjarnason I.

Lancet. 1995 Aug 26;346(8974):521-2. No abstract available.

PMID:
7658776
13.

Upper gastrointestinal tract.

Hayllar J.

Med J Aust. 1995 Apr 3;162(7):387; author reply 387, 389. No abstract available.

PMID:
7794351
14.

Nonsteroidal antiinflammatory drug-induced small intestinal inflammation and blood loss. Effects of sulfasalazine and other disease-modifying antirheumatic drugs.

Hayllar J, Smith T, Macpherson A, Price AB, Gumpel M, Bjarnason I.

Arthritis Rheum. 1994 Aug;37(8):1146-50.

PMID:
7914409
15.

Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

Bjarnason I, Hayllar J, MacPherson AJ, Russell AS.

Gastroenterology. 1993 Jun;104(6):1832-47. Review.

PMID:
8500743
16.

Gastro-duodenal damage due to non-steroidal anti-inflammatory drugs in children.

Hermaszewski R, Hayllar J, Woo P.

Br J Rheumatol. 1993 Jan;32(1):69-72.

PMID:
8422564
17.
18.

Gastroprotection and nonsteroidal anti-inflammatory drugs (NSAIDS). Rationale and clinical implications.

Hayllar J, Macpherson A, Bjarnason I.

Drug Saf. 1992 Mar-Apr;7(2):86-105. Review.

PMID:
1605904
19.

Sulphasalazine in ulcerative colitis: in memoriam?

Hayllar J, Bjarnason I.

Gut. 1991 May;32(5):462-3. Review. No abstract available.

Supplemental Content

Loading ...
Support Center